Toward a PSMA PET–mpMRI pathway for biopsy decision-making in men with suspected prostate cancer: interim results from the prospective BIOPSTAGE trial
Monica Celli, Roberta Gunelli, Fabio Ferroni, Matteo Costantini, Domenico Barone, Lorenzo Fantini, Eugenia Fragalà, Irene Marini, Valentina Di Iorio, Flavia Foca, Manuela Monti, Federica Matteucci, Paola Caroli · 2026
Read Toward a PSMA PET–mpMRI pathway for biopsy decision-making in men with suspected prostate cancer: interim results from the prospective BIOPSTAGE trial by Monica Celli, Roberta Gunelli, Fabio Ferroni, Matteo Costantini, Domenico Barone, Lorenzo Fantini, Eugenia Fragalà, Irene Marini, Valentina Di Iorio, Flavia Foca, Manuela Monti, Federica Matteucci, Paola Caroli (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12812660.txt.
Description
Monica Celli and co-authors reported early results in 2025 from the BIOPSTAGE trial, which tests two scans together for men who may have prostate cancer. The aim is to find serious cancer without surgery, and to cut the number of tissue samples taken. The catalog lists the paper under 2026, but the text itself gives 2025.
Ninety-six men at one centre had both scans before a biopsy. The MRI scan alone found most serious cancers but raised many false alarms. Adding the second scan, with set cut off values, raised accuracy and would have cut targeted samples by about two thirds. Two small serious cancers were missed by the second scan, so the authors urge care in use.
Catalog record
| CREATOR | Monica Celli, Roberta Gunelli, Fabio Ferroni, Matteo Costantini, Domenico Barone, Lorenzo Fantini, Eugenia Fragalà, Irene Marini, Valentina Di Iorio, Flavia Foca, Manuela Monti, Federica Matteucci, Paola Caroli |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |